The fund aims to build a portfolio of business-to-business (B2B) companies ranging from pre-seed to series A stages. The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting an internal rate of return (IRR) of 22 percentage and above.
“IXP was born out of a need we saw in the Indian start-up ecosystem. In fact, we conducted a pan-India survey to…

![[CITYPNG.COM]White Google Play PlayStore Logo – 1500×1500](https://startupnews.fyi/wp-content/uploads/2025/08/CITYPNG.COMWhite-Google-Play-PlayStore-Logo-1500x1500-1-630x630.png)